rs3745647

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000590627.5(GCDH):​n.232T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.037 in 1,613,942 control chromosomes in the GnomAD database, including 1,326 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.048 ( 241 hom., cov: 33)
Exomes 𝑓: 0.036 ( 1085 hom. )

Consequence

GCDH
ENST00000590627.5 non_coding_transcript_exon

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.0910

Publications

5 publications found
Variant links:
Genes affected
GCDH (HGNC:4189): (glutaryl-CoA dehydrogenase) The protein encoded by this gene belongs to the acyl-CoA dehydrogenase family. It catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA and CO(2) in the degradative pathway of L-lysine, L-hydroxylysine, and L-tryptophan metabolism. It uses electron transfer flavoprotein as its electron acceptor. The enzyme exists in the mitochondrial matrix as a homotetramer of 45-kD subunits. Mutations in this gene result in the metabolic disorder glutaric aciduria type 1, which is also known as glutaric acidemia type I. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 12. [provided by RefSeq, Mar 2013]
GCDH Gene-Disease associations (from GenCC):
  • glutaryl-CoA dehydrogenase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P, Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 19-12891570-T-C is Benign according to our data. Variant chr19-12891570-T-C is described in ClinVar as Benign. ClinVar VariationId is 255394.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0859 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GCDHNM_000159.4 linkc.127+48T>C intron_variant Intron 3 of 11 ENST00000222214.10 NP_000150.1
GCDHNR_102317.1 linkn.283T>C non_coding_transcript_exon_variant Exon 3 of 11
GCDHNM_013976.5 linkc.127+48T>C intron_variant Intron 3 of 11 NP_039663.1
GCDHNR_102316.1 linkn.235+48T>C intron_variant Intron 3 of 11

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GCDHENST00000222214.10 linkc.127+48T>C intron_variant Intron 3 of 11 1 NM_000159.4 ENSP00000222214.4 Q92947-1

Frequencies

GnomAD3 genomes
AF:
0.0480
AC:
7303
AN:
152178
Hom.:
243
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0883
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0381
Gnomad ASJ
AF:
0.0279
Gnomad EAS
AF:
0.00770
Gnomad SAS
AF:
0.0290
Gnomad FIN
AF:
0.00903
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0381
Gnomad OTH
AF:
0.0417
GnomAD2 exomes
AF:
0.0338
AC:
8497
AN:
251134
AF XY:
0.0328
show subpopulations
Gnomad AFR exome
AF:
0.0909
Gnomad AMR exome
AF:
0.0254
Gnomad ASJ exome
AF:
0.0256
Gnomad EAS exome
AF:
0.00658
Gnomad FIN exome
AF:
0.0109
Gnomad NFE exome
AF:
0.0377
Gnomad OTH exome
AF:
0.0372
GnomAD4 exome
AF:
0.0359
AC:
52451
AN:
1461646
Hom.:
1085
Cov.:
35
AF XY:
0.0357
AC XY:
25925
AN XY:
727104
show subpopulations
African (AFR)
AF:
0.0926
AC:
3100
AN:
33474
American (AMR)
AF:
0.0264
AC:
1179
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0258
AC:
674
AN:
26134
East Asian (EAS)
AF:
0.0122
AC:
483
AN:
39698
South Asian (SAS)
AF:
0.0323
AC:
2785
AN:
86242
European-Finnish (FIN)
AF:
0.0123
AC:
655
AN:
53392
Middle Eastern (MID)
AF:
0.0425
AC:
239
AN:
5618
European-Non Finnish (NFE)
AF:
0.0369
AC:
41017
AN:
1111980
Other (OTH)
AF:
0.0384
AC:
2319
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
3173
6345
9518
12690
15863
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1540
3080
4620
6160
7700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0480
AC:
7307
AN:
152296
Hom.:
241
Cov.:
33
AF XY:
0.0452
AC XY:
3370
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0883
AC:
3668
AN:
41562
American (AMR)
AF:
0.0380
AC:
582
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0279
AC:
97
AN:
3472
East Asian (EAS)
AF:
0.00772
AC:
40
AN:
5180
South Asian (SAS)
AF:
0.0286
AC:
138
AN:
4830
European-Finnish (FIN)
AF:
0.00903
AC:
96
AN:
10630
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0381
AC:
2589
AN:
68002
Other (OTH)
AF:
0.0412
AC:
87
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
363
726
1088
1451
1814
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0432
Hom.:
39
Bravo
AF:
0.0514
Asia WGS
AF:
0.0260
AC:
89
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Glutaric aciduria, type 1 Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_noAF
Benign
-0.88
CADD
Benign
13
DANN
Benign
0.66
PhyloP100
-0.091
PromoterAI
0.045
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3745647; hg19: chr19-13002384; API